While their study focused on the lungs and cystic fibrosis, our findings demonstrated the reduction of phosphorylated STAT3 in the kidneys of a salt-induced hypertensive model, adding to the growing evidence of hAAT’s potential as a therapeutic agent across multiple organ systems. The gene discussed is STAT3; the disease is cystic fibrosis.